Aquestive Therapeutics In... (AQST)
NASDAQ: AQST
· Real-Time Price · USD
4.12
0.01 (0.24%)
At close: Aug 15, 2025, 3:47 PM
Aquestive Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 60.54M | 68.66M | 71.55M | 77.89M | 89.87M | 95.2M | 23.87M | 24.92M | 22.44M | 26.88M | 27.27M | 18.65M | 17.7M | 14.74M | 28.02M | 31.16M | 34.23M | 27.5M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 2M | 3M | 3M | 3M | 3M | 4M | 4M | 4M | 4M | 5M | 5M | n/a | 5M | 6M | 6M | 6M | 6M | 7M |
Other Long-Term Assets | 1.21M | 1.22M | 1.22M | 1.23M | 1.24M | 1.42M | 1.44M | 5.45M | 5.47M | 6.49M | 6.45M | 5.89M | 5.9M | 6.89M | 6.9M | 6.91M | 6.91M | 7.83M |
Receivables | 11.86M | 10.44M | 7.34M | 9.68M | 6M | 8.32M | 8.47M | 8.55M | 10.1M | 7.55M | 4.7M | 10.74M | 19.16M | 19.9M | 12.12M | 13.64M | 12.13M | 10.21M |
Inventory | 8.13M | 7.2M | 6.04M | 7.02M | 6.97M | 7.73M | 6.77M | 7.08M | 5.95M | 6.98M | 5.78M | 6.72M | 5.01M | 4.63M | 4.04M | 2.86M | 2.84M | 2.8M |
Other Current Assets | 1.2M | 2.87M | 3.29M | 1.97M | 1.18M | 2.12M | 1.85M | 1.91M | 1.3M | 2.29M | 2.13M | 1.98M | 1.64M | 3.32M | 3.08M | 2.54M | 1.8M | 3.94M |
Total Current Assets | 81.72M | 89.17M | 88.22M | 96.57M | 104.01M | 113.38M | 40.97M | 42.46M | 39.79M | 43.71M | 39.89M | 38.09M | 43.51M | 42.59M | 47.26M | 50.21M | 51M | 44.44M |
Property-Plant & Equipment | 8.77M | 8.85M | 8.98M | 9.16M | 9.36M | 9.49M | 9.74M | 10.22M | 10.38M | 9.7M | 7.9M | 6.38M | 6.88M | 7.02M | 7.78M | 8.11M | 8.89M | 9.56M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | 1.24M | 1.28M | 1.32M | 1.36M | 1.4M | 1.44M | 1.49M | 25K | 38K | 51K | 64K | 76K | 89K |
Total Long-Term Assets | 11.98M | 13.06M | 13.2M | 13.39M | 13.59M | 16.14M | 16.45M | 16.99M | 17.21M | 17.58M | 15.79M | 13.76M | 12.8M | 13.94M | 14.73M | 15.08M | 15.88M | 17.48M |
Total Assets | 93.7M | 102.23M | 101.42M | 109.96M | 117.61M | 129.52M | 57.42M | 59.45M | 56.99M | 61.28M | 55.67M | 51.84M | 56.31M | 56.53M | 61.99M | 65.29M | 66.88M | 61.92M |
Account Payables | 11.95M | 12.28M | 10.29M | 7.57M | 5.7M | 10.52M | 8.93M | 9.99M | 10.69M | 12.44M | 9.95M | 11.07M | 8.89M | 8.5M | 8.31M | 6.21M | 8.1M | 6.69M |
Deferred Revenue | 1.09M | 1.05M | 1.05M | 1.05M | 1.05M | 1.55M | 1.55M | 2.64M | 3.99M | 4.76M | 1.51M | 774K | 1.6M | 1.6M | 765K | 767K | 642K | 437K |
Short-Term Debt | 5.11M | 27K | 26K | 25K | 24K | 23K | 22K | 4.61M | 18.36M | 17.2M | 18.7M | 14.22M | 9.75M | 6.56M | 2.02M | 7.72M | 5.15M | 3.86M |
Other Current Liabilities | 1.47M | 3.28M | 1M | 4.46M | 3.67M | 2.64M | 5.12M | 3.62M | 3.8M | 3.55M | 7.54M | 6.85M | 5.37M | 3.33M | 7.19M | 6.44M | 5.82M | 5.56M |
Total Current Liabilities | 23.16M | 18.3M | 18.86M | 15.15M | 13.89M | 18.06M | 18.31M | 24.06M | 38.65M | 40.38M | 39.68M | 36.56M | 29.64M | 24.18M | 21.96M | 25.04M | 23.04M | 20.05M |
Long-Term Debt | 116.48M | 33.75M | 32.5M | 31.25M | 30.01M | 108.5M | 27.51M | 34.55M | 84.26M | 89.33M | 97.56M | 38.67M | 105.66M | 108.03M | 110.61M | 89.29M | 87.07M | 84.58M |
Other Long-Term Liabilities | 2.05M | 86.55M | 85.24M | 83.6M | n/a | n/a | 80.34M | 65.52M | 2.01M | 2.06M | 2.03M | 65.47M | 2.38M | 1.86M | 2.48M | 1.81M | 1.77M | 1.76M |
Total Long-Term Liabilities | 143.13M | 144.87M | 142.72M | 140.23M | 139.19M | 147.77M | 145.6M | 138.32M | 124.99M | 130.14M | 134.55M | 123.1M | 123.03M | 125.49M | 122.16M | 100.6M | 97.61M | 93.67M |
Total Liabilities | 166.29M | 163.16M | 161.58M | 155.38M | 153.08M | 165.82M | 163.91M | 162.38M | 163.65M | 170.52M | 174.23M | 159.66M | 152.67M | 149.67M | 144.13M | 125.64M | 120.64M | 113.72M |
Total Debt | 126.26M | 39.13M | 38M | 36.87M | 35.72M | 34.48M | 33.32M | 45.04M | 45.12M | 48.42M | 56.09M | 55.09M | 55.99M | 56.88M | 56.42M | 43.44M | 42.46M | 41.48M |
Common Stock | 99K | 99K | 91K | 91K | 91K | 90K | 69K | 67K | 62K | 56K | 55K | 54K | 53K | 41K | 41K | 40K | 39K | 36K |
Retained Earnings | -399.69M | -386.14M | -363.21M | -346.16M | -334.65M | -331.9M | -319.08M | -310.97M | -308.93M | -303.14M | -311.21M | -298.86M | -286.32M | -270.02M | -256.8M | -227.85M | -213.3M | -200.93M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38.52M | -37.83M |
Shareholders Equity | -72.59M | -60.93M | -60.16M | -45.42M | -35.48M | -36.3M | -106.49M | -102.93M | -106.65M | -109.23M | -118.55M | -107.82M | -96.36M | -93.14M | -82.13M | -60.34M | -53.77M | -51.8M |
Total Investments | 2M | 3M | 3M | 3M | 3M | 4M | 4M | 4M | 4M | 5M | 5M | n/a | 5M | 6M | 6M | 6M | 6M | 7M |